NHI.no
Annonse
Informasjon

Postpolio syndrom

Postpolio syndrom er karakterisert av ny muskelsvakhet, smerte, tretthet og praktisk funksjonstap som utvikler seg mange år etter akutt poliomyelitt.

Sist oppdatert:

2. nov. 2020

Vil du vite mer

Dette dokumentet er basert på det profesjonelle dokumentet Postpolio syndrom . Referanselisten for dette dokumentet vises nedenfor

  1. Muniz FM, Herbison G. Postpolio syndrome. eMedicine Journal 2001; 2: September 17.
  2. Bouza C, Munoz A, Amate JM. Postpolio syndrome: a challenge to the health-care system. Health Policy. 2005 Jan. 71(1):97-106.
  3. Grimby G. Postpolio - symptomatologi och åtgärder. Ugeskr Læger 2002; 164: 2752-6. PubMed
  4. Farbu E, Gilhus NE, Barnes MP, et al. EFNS guidelinle on diagnosis and management of post-polio syndrome. Report of an EFNS task force. Eur J Neurol 2006; 13: 795-801. PubMed
  5. Jubelt B. Post-Polio Syndrome. Curr Treat Options Neurol. 2004 Mar;6(2):87-93. PMID: 14759341. PubMed
  6. Tiffreau V, Rapin A, Serafi R, et al. Post-polio syndrome and rehabilitation. Ann Phys Rehabil Med. 2010 Feb;53(1):42-50. Epub 2009 Dec 30. PMID: 20044320. PubMed
  7. Baj A, Monaco S, Zanusso G, et al. Virology of the post-polio syndrome. Future Virology 2007; 2: 183-92. PubMed
  8. Bertolasi L, Acler M, dall'Ora E, Gajofatto A, Frasson E, Tocco P, et al. Risk factors for post-polio syndrome among an Italian population: a case-control study. Neurol Sci. 2012 Dec. 33(6):1271-5.
  9. Werhagen L, Borg K. Impact of pain on quality of life in patients with post-polio syndrome. J Rehabil Med. 2013 Feb. 45(2):161-3.
  10. Gonzalez H, Khademi M, Andersson M et al. Prior poliomyelitis - evidence of cytokine production in the central nervous system. J Neurol Sci 2002; 205: 9-13. PubMed
  11. Dalakas MC. Pro-inflammatory cytokines and motor neuron dysfunction: is there a connection in post-polio syndrome? J Neurol Sci 2002; 205: 5-8. PubMed
  12. Correa JC, Rocco CC, de Andrade DV, et al. Electromyographic and neuromuscular analysis in patients with post-polio syndrome. Electromyogr Clin Neurophysiol. 2008 Nov-Dec. 48(8):329-33.
  13. Simionescu L, Jubelt B. Post-polio syndrome. UpToDate, last updated Feb 13, 2013 . UpToDate
  14. Farbu E, Rekand T, Vik-Mo E, Lygren H, Gilhus NE, Aarli JA. Post-polio syndrome patients treated with intravenous immunoglobulin: a double-blinded randomized controlled pilot study. Eur J Neurol 2007; 14: 60-5. PubMed
  15. Gonzales H, Sunnerhagen KS, Sjöberg I, et al. Intravenous immunoglobulin for post-polio syndrome: a randomised controlled trial. Lancet Neurol 2006; 5: 493-500. PubMed
  16. Koopman FS, Beelen A, Gilhus NE, de Visser M, Nollet F. Treatment for postpolio syndrome. Cochrane Database of Systematic Reviews 2015, Issue 5. Art. No.: CD007818. DOI: 10.1002/14651858.CD007818.pub3. DOI
  17. Trojan DA, Cashman NR. Post-poliomyelitis syndrome. Muscle Nerve 2005; 31: 6-19. PubMed
  18. Jubelt B, Agre JC. Characteristics and management of post-polio syndrome. JAMA 2000; 284: 412-4. Journal of the American Medical Association
  19. Howard RS. Poliomyelitis and the pospolio syndrome. BMJ 2005; 330: 1314-9. PubMed
  20. Howard RS, Davidson C. Long term ventilation in neurogenic respiratory failure. J Neurol Neurosurg Psychiatry 2003; 74(suppl III): iii24-30.
  21. Farbu E, Rekand T, Gilhus NE, et al. Intravenøst immunglobulin ved postpoliosyndrom. Tidsskr Nor Lægeforen 2004; 124: 2357-8. PubMed
  22. Dalakas MC. Mechanisms of action of IVIg and therapeutic considerations in the treatment of acute and chronic demyelinating neuropathies. Neurology 2002; 59: S13-21. Neurology
  23. On AY, Oncu J, Uludag B, Ertekin C. Effects of lamotrigine on the symptoms and life qualities of patients with post polio syndrome: a randomized, controlled study. NeuroRehabilitation 2005; 20: 245-51. PubMed
  24. Wilson H, Kidd D, Howard RS, Williams AJ. Calf hypertrophy following paralytic poliomyelitis Postgrad Med J 2000; 76: 179-81. PubMed
Annonse
Annonse